GB2062464B - Eburnamenine derivatives - Google Patents

Eburnamenine derivatives

Info

Publication number
GB2062464B
GB2062464B GB8035112A GB8035112A GB2062464B GB 2062464 B GB2062464 B GB 2062464B GB 8035112 A GB8035112 A GB 8035112A GB 8035112 A GB8035112 A GB 8035112A GB 2062464 B GB2062464 B GB 2062464B
Authority
GB
United Kingdom
Prior art keywords
eburnamenine derivatives
eburnamenine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8035112A
Other languages
English (en)
Other versions
GB2062464A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of GB2062464A publication Critical patent/GB2062464A/en
Application granted granted Critical
Publication of GB2062464B publication Critical patent/GB2062464B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8035112A 1979-11-02 1980-10-31 Eburnamenine derivatives Expired GB2062464B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI733A HU181940B (en) 1979-11-02 1979-11-02 Process for producing solutions of vincane derivatives for parentheral application

Publications (2)

Publication Number Publication Date
GB2062464A GB2062464A (en) 1981-05-28
GB2062464B true GB2062464B (en) 1983-12-07

Family

ID=11001115

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8035112A Expired GB2062464B (en) 1979-11-02 1980-10-31 Eburnamenine derivatives

Country Status (24)

Country Link
US (1) US4344950A (enExample)
JP (1) JPS56123911A (enExample)
AR (1) AR223735A1 (enExample)
AT (1) AT377914B (enExample)
AU (1) AU533715B2 (enExample)
BE (1) BE885987A (enExample)
CA (1) CA1159367A (enExample)
CH (1) CH645019A5 (enExample)
CS (1) CS226417B2 (enExample)
DD (1) DD153760A5 (enExample)
DE (1) DE3041368A1 (enExample)
DK (1) DK464680A (enExample)
FI (1) FI803401A7 (enExample)
FR (1) FR2468373A1 (enExample)
GB (1) GB2062464B (enExample)
HU (1) HU181940B (enExample)
IL (1) IL61310A (enExample)
IT (1) IT1209367B (enExample)
NL (1) NL8005980A (enExample)
NO (1) NO803254L (enExample)
PH (1) PH17037A (enExample)
SE (1) SE8007569L (enExample)
YU (1) YU278880A (enExample)
ZA (1) ZA806468B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺
CN112649522B (zh) * 2020-11-30 2022-02-22 海南葫芦娃药业集团股份有限公司 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
US3159542A (en) * 1962-12-31 1964-12-01 American Cyanamid Co Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891B1 (enExample) * 1972-07-13 1975-08-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Also Published As

Publication number Publication date
PH17037A (en) 1984-05-17
FR2468373A1 (fr) 1981-05-08
DK464680A (da) 1981-05-03
FI803401L (fi) 1981-05-03
JPS56123911A (en) 1981-09-29
AU533715B2 (en) 1983-12-08
AT377914B (de) 1985-05-28
IT1209367B (it) 1989-07-16
CH645019A5 (de) 1984-09-14
HU181940B (en) 1983-11-28
IL61310A0 (en) 1980-12-31
AU6400480A (en) 1981-05-07
US4344950A (en) 1982-08-17
FI803401A7 (fi) 1981-05-03
FR2468373B1 (enExample) 1984-12-28
NL8005980A (nl) 1981-06-01
CS226417B2 (en) 1984-03-19
YU278880A (en) 1984-04-30
BE885987A (fr) 1981-02-16
AR223735A1 (es) 1981-09-15
SE8007569L (sv) 1981-05-03
CA1159367A (en) 1983-12-27
DE3041368A1 (de) 1981-05-14
IL61310A (en) 1984-08-31
NO803254L (no) 1981-05-04
IT8025683A0 (it) 1980-10-31
DD153760A5 (de) 1982-02-03
GB2062464A (en) 1981-05-28
ZA806468B (en) 1981-10-28
ATA527980A (de) 1984-10-15

Similar Documents

Publication Publication Date Title
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
NZ193801A (en) 7-amino-cephalosporin derivatives
NZ193799A (en) 3-vinyl-cephalosporin derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
MY8500273A (en) Pyrrlidine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2053899B (en) Terahydrophthalamide derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
MY8400201A (en) Isopropylamino-pyrimidine derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
PH15098A (en) 15-sulfonamidoprostaglandin derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
GB2065110B (en) Decaprenylamine derivatives
GB2042508B (en) 3-alkoxy-penem derivatives
GB2065109B (en) Decaprenylamine derivatives
GB2045234B (en) Anilionotropone derivatives
GB2122186B (en) Oxapenem derivatives
GB2122600B (en) Hexahydronaphthacene derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee